AzTrials
AzTrials

StrokeVIBRATACNCT04737018

Impact of a Focal Muscle Vibration Protocol in Front of the the Anterior Tibial Muscle in the Subacute Post-stroke Period on Motor Recovery in Hemiplegic Patients.

A study testing Fugl-Meyer Assessment (FMA), Medical Research Concil (MRC) and 2 Minute Walk Test (2MWT) in people with Stroke, run by Centre Hospitalier Universitaire de Saint Etienne at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In about 40 percent of cases, after a stroke, neuromotor impairment leads to activity limitations and the development of chronic functional disorders, which have a significant impact on patient autonomy. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke
What is being tested?
Fugl-Meyer Assessment (FMA), Medical Research Concil (MRC) and 2 Minute Walk Test (2MWT)
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
38 participants
Where
2 sitesFrance
Study dates
14 May 2021to 15 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Having had a stroke (with or without previous stroke) and being in the early subacute phase (between 14 days and 3 months of stroke).
  • Responsible for a motor deficit in the right or left lower limb.
  • No neurological history other than stroke.

Who cannot join

  • Multifocal stroke
  • Patient having received a botulinum toxin injection to the lower limb to be vibrated

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Centre Hospitalier Universitaire de Saint-Etienne

    Saint-Etienne, 42055

  • Le Clos Champirol - Service de Médecine Physique et de Réadaptation

    Saint-Priest-en-Jarez

Other trials in France

About this study

In about 40 percent of cases, after a stroke, neuromotor impairment leads to activity limitations and the development of chronic functional disorders, which have a significant impact on patient autonomy.

In the early subacute phase, motor deficit in foot lifters is one of the factors limiting standing posture and ambulation, which is ultimately difficult to rehabilitate due to the lack of available techniques for obtaining early onset of useful active voluntary contraction.

The use of muscular focal vibration therapy, applied to relaxed muscle, may be of interest due to the portability and availability of the system and the neuromotor benefits demonstrated in healthy subjects and in acute and chronic post-stroke patients.

Conditions
Stroke
Being tested
Fugl-Meyer Assessment (FMA), Medical Research Concil (MRC), 2 Minute Walk Test (2MWT), Timed Up & Go Test, Modified Ashworth Scale
Keywords
muscle vibration protocol, anterior tibia muscle, hemiplegic patient
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fugl-Meyer Assessment (FMA)Other

    assessment of motor skills : measurement of the intensity of reflexes, as well as an assessment of voluntary movements and motor coordination Score from 0 to 34

  • Medical Research Concil (MRC)Other

    evaluation of muscular strength score from 0 to 5

  • 2 Minute Walk Test (2MWT)Other

    Assess functional walking and aerobic abilities

  • Timed Up & Go TestOther

    measures the time it takes to get up from a chair, walk 10 feet, turn around, return to the seat and sit down

  • Modified Ashworth ScaleOther

    score from 0 to 4 evaluation of spasticity

  • Postural Assessment Scale for StrokeOther

    score from 0 to 36 measures the patient's ability to maintain stable postures and balance in changes of position

  • posturographic recordingDevice

    analysis of static equilibrium parameters and positional measurement of the center of gravity on the Winposturo platform

  • vibration programOther

    a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm

  • sham programOther

    a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.

Study groups in NCT04737018
Study groupRoleWhat they receive
vibration programExperimentala 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm
Receives: Other: Fugl-Meyer Assessment (FMA); Other: Medical Research Concil (MRC); Other: 2 Minute Walk Test (2MWT); Other: Timed Up & Go Test; Other: Modified Ashworth Scale; Other: Postural Assessment Scale for Stroke; Device: posturographic recording; Other: vibration program
sham programSham comparatora 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.
Receives: Other: Fugl-Meyer Assessment (FMA); Other: Medical Research Concil (MRC); Other: 2 Minute Walk Test (2MWT); Other: Timed Up & Go Test; Other: Modified Ashworth Scale; Other: Postural Assessment Scale for Stroke; Device: posturographic recording; Other: sham program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. score of Fugl Meyer Assessment (lower limbs)

    score from 0 to 34 Stroke-specific performance-based disability index that quantitatively assesses analytical motor skills in the lower limb.

    Measured: day 30

Secondary outcomes (6)
  1. score of Fugl Meyer Assessment (lower limbs)

    score from 0 to 34 Stroke-specific performance-based disability index that quantitatively assesses analytical motor skills in the lower limb.

    Measured: day 0, day 15, day 30 and month 2

  2. score of Medical Research Concil

    score of 0 (absence of contraction) to 5 (normal force)

    Measured: day 0, day 15, day 30 and month 2

  3. assess functional walking ability

    measured with 2 Minute Walk Test

    Measured: day 0, day 15, day 30 and month 2

  4. score of postural assessment scale for stroke

    measures the patient's ability to maintain stable postures, as well as balance in changes of position score of 0 (cannot perform the activity) to 36 (can perform the activity)

    Measured: day 0, day 15, day 30 and month 2

  5. analysis of static equilibrium

    with Winposturo platform

    Measured: day 0, day 15, day 30 and month 2

  6. positional measurement of the center of gravity

    with Winposturo platform

    Measured: day 0, day 15, day 30 and month 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2021
  2. Study start14 May 2021
  3. Primary completion29 Sep 2023
  4. Study completion15 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04737018
Sponsor's protocol ID
20CH152
Other IDs
2020-A03189-30
Acronym
VIBRATAC
Status last verified
Dec 2023
First submitted
28 Jan 2021
Last updated
27 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Fugl-Meyer Assessment (FMA), Medical Research Concil (MRC) and 2 Minute Walk Test (2MWT) in people with Stroke, run by Centre Hospitalier Universitaire de Saint Etienne at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

score of Fugl Meyer Assessment (lower limbs) (time frame: day 30). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in